These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival. Kindy-Degnan NA; Char DH; Castro JR; Kroll S; Stone RD; Quivey JM; Phillips TL; Irvine AR Am J Ophthalmol; 1989 Feb; 107(2):114-20. PubMed ID: 2913804 [TBL] [Abstract][Full Text] [Related]
26. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [TBL] [Abstract][Full Text] [Related]
27. Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy. Char DH; Kroll S; Quivey JM; Castro J Br J Ophthalmol; 1996 Feb; 80(2):117-24. PubMed ID: 8814740 [TBL] [Abstract][Full Text] [Related]
28. Uveal melanoma: development of metastases after helium ion irradiation. Nowakowski VA; Ivery G; Castro JR; Char DH; Linstadt DE; Ahn D; Phillips TL; Quivey JM; Decker M; Petti PL Radiology; 1991 Jan; 178(1):277-80. PubMed ID: 1898536 [TBL] [Abstract][Full Text] [Related]
29. Effect of pre-enucleation irradiation on the survival of patients with uveal melanoma. Günalp I; Batioğlu F Ophthalmologica; 1998; 212(4):231-5. PubMed ID: 9672210 [TBL] [Abstract][Full Text] [Related]
30. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma. Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631 [TBL] [Abstract][Full Text] [Related]
31. Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation. Char DH; Castro JR; Quivey JM; Phillips TL; Irvine AR; Stone RD; Kroll S Ophthalmology; 1989 Dec; 96(12):1708-15. PubMed ID: 2695875 [TBL] [Abstract][Full Text] [Related]
33. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676 [TBL] [Abstract][Full Text] [Related]
34. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control. Quivey JM; Augsburger J; Snelling L; Brady LW Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107 [TBL] [Abstract][Full Text] [Related]